C. Gabay, Interleukin-6 and chronic inflammation, Arthritis Res. Ther, vol.8, p.3, 2006.

J. Cavaillon, C. Adrie, C. Fitting, and M. Adib-conquy, Endotoxin tolerance: is there a clinical relevance?, J. Endotoxin Res, vol.9, pp.101-107, 2003.

L. Calderón-garcidueñas, M. Macías-parra, H. J. Hoffmann, G. Valencia-salazar, C. Henríquez-roldán et al., Immunotoxicity and environment: Immunodysregulation and systemic inflammation in children, Toxicol. Pathol, vol.37, pp.161-169, 2009.

V. Chiurchiù, L. Battistini, and M. Maccarrone, Endocannabinoid signalling in innate and adaptive immunity, Immunology, vol.144, pp.352-364, 2015.

V. Chiurchiù, Endocannabinoids and immunity, Cannabis Cannabinoid Res, vol.1, pp.59-66, 2016.

D. Marzo, V. , M. Bifulco, and L. De-petrocellis, The endocannabinoid system and its therapeutic exploitation, Nat. Rev. Drug Discov, vol.3, pp.771-784, 2004.

M. Karsak, E. Gaffal, R. Date, L. Wang-eckhardt, J. Rehnelt et al., Attenuation of allergic contact dermatitis through the endocannabinoid system, Science, vol.316, pp.1494-1497, 2007.

J. Sardinha, M. E. Kelly, J. Zhou, and C. Lehmann, Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis, Mediators Inflamm, p.978678, 2014.

K. Mukai, M. Tsai, H. Saito, and S. J. Galli, Mast cells as sources of cytokines, chemokines, and growth factors, Immunol. Rev, vol.282, pp.121-150, 2018.

B. Frossi, F. Mion, C. Tripodo, M. P. Colombo, and C. E. Pucillo, Rheostatic functions of mast cells in the control of innate and adaptive immune responses, Trends Immunol, vol.38, pp.648-656, 2017.

M. F. Gurish and K. F. Austen, Developmental origin and functional specialization of mast cell subsets, Immunity, vol.37, pp.25-33, 2012.

R. Gentek, C. Ghigo, G. Hoeffel, M. J. Bulle, R. Msallam et al., Hemogenic endothelial fate mapping reveals dual developmental origin of mast cells, Immunity, vol.48, pp.1160-1171, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02024628

D. F. Dwyer, N. A. Barrett, and K. F. Austen, Expression profiling of constitutive mast cells reveals a unique identity within the immune system, Nat. Immunol, vol.17, pp.878-887, 2016.

U. Blank, I. K. Madera-salcedo, L. Danelli, J. Claver, N. Tiwari et al., Vesicular trafficking and signaling for cytokine and chemokine secretion in mast cells, Front. Immunol, vol.5, p.453, 2014.

H. Xu, N. R. Bin, and S. Sugita, Diverse exocytic pathways for mast cell mediators, Biochem. Soc. Trans, vol.46, pp.235-247, 2018.

X. Xu, D. Zhang, N. Lyubynska, P. J. Wolters, N. P. Killeen et al., Mast cells protect mice from Mycoplasma pneumonia, Am. J. Respir. Crit. Care Med, vol.173, pp.219-225, 2006.

N. O. Gekara and S. Weiss, Mast cells initiate early anti-Listeria host defences, Cell. Microbiol, vol.10, pp.225-236, 2008.

R. E. Sutherland, J. S. Olsen, A. Mckinstry, S. A. Villalta, and P. J. Wolters, Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing, J. Immunol, vol.181, pp.5598-5605, 2008.

A. L. St-john and S. N. Abraham, Innate immunity and its regulation by mast cells, J. Immunol, vol.190, pp.4458-4463, 2013.

B. Echtenacher, D. N. Männel, and L. Hültner, Critical protective role of mast cells in a model of acute septic peritonitis, Nature, vol.381, pp.75-77, 1996.

V. Supajatura, H. Ushio, A. Nakao, K. Okumura, C. Ra et al., Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4, J. Immunol, vol.167, pp.2250-2256, 2001.

N. Dietrich, M. Rohde, R. Geffers, A. Kröger, H. Hauser et al., Mast cells elicit proinflammatory but not type I interferon responses upon activation of TLRs by bacteria, Proc. Natl. Acad. Sci. USA, vol.107, pp.8748-8753, 2010.

V. Supajatura, H. Ushio, A. Nakao, S. Akira, K. Okumura et al., Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity, J. Clin. Invest, vol.109, pp.1351-1359, 2002.

S. K. Biswas and E. Lopez-collazo, Endotoxin tolerance: new mechanisms, molecules and clinical significance, Trends Immunol, vol.30, pp.475-487, 2009.

L. M. Sly, M. J. Rauh, J. Kalesnikoff, C. H. Song, and G. Krystal, LPSinduced upregulation of SHIP is essential for endotoxin tolerance, Immunity, vol.21, pp.227-239, 2004.

K. Kobayashi, L. D. Hernandez, J. E. Galán, C. A. Janeway, R. Medzhitov et al., IRAK-M is a negative regulator of Toll-like receptor signaling, Cell, vol.110, pp.191-202, 2002.

R. J. Carmody, Q. Ruan, S. Palmer, B. Hilliard, and Y. H. Chen, Negative regulation of toll-like receptor signaling by NF-kappaB ubiquitination blockade, Science, vol.317, pp.675-678, 2007.

F. Correa, M. Hernangómez, L. Mestre, F. Loría, A. Spagnolo et al., Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: Roles of ERK1/2, JNK, and NF-kappaB, Glia, vol.58, pp.135-147, 2010.

F. Randow, U. Syrbe, C. Meisel, D. Krausch, H. Zuckermann et al., Mechanism of endotoxin desensitization: Involvement of interleukin 10 and transforming growth factor beta, J. Exp. Med, vol.181, pp.1887-1892, 1995.

A. M. Piliponsky, C. C. Chen, M. A. Grimbaldeston, S. M. Burns-guydish, J. Hardy et al., Mast cellderived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice, Am. J. Pathol, vol.176, pp.926-938, 2010.

A. Dahdah, G. Gautier, T. Attout, F. Fiore, E. Lebourdais et al., Mast cells aggravate sepsis by inhibiting peritoneal macrophage phagocytosis, J. Clin. Invest, vol.124, pp.4577-4589, 2014.

Y. I. Nigo, M. Yamashita, K. Hirahara, R. Shinnakasu, M. Inami et al., Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function, Proc. Natl. Acad. Sci. USA, vol.103, pp.2286-2291, 2006.

R. Saluja, I. Delin, G. P. Nilsson, and M. Adner, Fc?R1-mediated mast cell reactivity is amplified through prolonged Toll-like receptor-ligand treatment, PLoS One, vol.7, p.43547, 2012.

K. Sugawara, N. Zákány, T. Hundt, V. Emelianov, D. Tsuruta et al., Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ, J. Allergy Clin. Immunol, vol.132, pp.182-193, 2013.

L. Hanus, A. Breuer, S. Tchilibon, S. Shiloah, D. Goldenberg et al., HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor, Proc. Natl. Acad. Sci. USA, vol.96, pp.14228-14233, 1999.

I. K. Madera-salcedo, S. L. Cruz, and C. González-espinosa, Morphine prevents lipopolysaccharide-induced TNF secretion in mast cells blocking IkB kinase activation and SNAP-23 phosphorylation: Correlation with the formation of a b-arrestin/TRAF6 complex, J. Immunol, vol.191, pp.3400-3409, 2013.

N. Tiwari, C. C. Wang, C. Brochetta, G. Ke, F. Vita et al., VAMP-8 segregates mast cell-preformed mediator exocytosis from cytokine trafficking pathways, Blood, vol.111, pp.3665-3674, 2008.

J. Medina-tamayo, E. Sánchez-miranda, H. Balleza-tapia, X. Ambriz, M. E. Cid et al., Super-oxidized solution inhibits IgE-antigen-induced degranulation and cytokine release in mast cells, Int. Immunopharmacol, vol.7, pp.1013-1024, 2007.

S. Jiang, Y. Fu, J. Williams, J. Wood, L. Pandarinathan et al., Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells, PLoS One, vol.2, p.641, 2007.

F. Guzmán-mejía, C. López-rubalcava, and C. González-espinosa, Stimulation of nAchRa7 receptor inhibits TNF synthesis and secretion in response to LPS treatment of mast cells by targeting ERK1/2 and TACE activation, J. Neuroimmune Pharmacol, vol.13, pp.39-52, 2018.

M. A. Grimbaldeston, C. C. Chen, A. M. Piliponsky, M. Tsai, S. Y. Tam et al., Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo, Am. J. Pathol, vol.167, pp.835-848, 2005.

I. K. Madera-salcedo, S. L. Cruz, and C. Gonzalez-espinosa, Morphine decreases early peritoneal innate immunity responses in Swiss-Webster and C57BL6/J mice through the inhibition of mast cell TNF-a release, J. Neuroimmunol, vol.232, pp.101-107, 2011.

J. Medina-tamayo, A. Ibarra-sánchez, A. Padilla-trejo, and C. González-espinosa, IgE-dependent sensitization increases responsiveness to LPS but does not modify development of endotoxin tolerance in mast cells, Inflamm. Res, vol.60, pp.19-27, 2011.

T. Bisogno, S. Maurelli, D. Melck, L. D. Petrocellis, and V. D. Marzo, Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes, J. Biol. Chem, vol.272, pp.3315-3323, 1997.

Y. Xiong and A. E. Medvedev, Induction of endotoxin tolerance in vivo inhibits activation of IRAK4 and increases negative regulators IRAK-M, SHIP-1, and A20, J. Leukoc. Biol, vol.90, pp.1141-1148, 2011.

A. Drobek, J. Kralova, T. Skopcova, M. Kucova, P. Novák et al., PSTPIP2, a protein associated with autoinflammatory disease, interacts with inhibitory enzymes SHIP1 and csk, J. Immunol, vol.195, pp.3416-3426, 2015.

R. Brooks, G. M. Fuhler, S. Iyer, M. J. Smith, M. Y. Park et al., SHIP1 inhibition increases immunoregulatory capacity and triggers apoptosis of hematopoietic cancer cells, J. Immunol, vol.184, pp.3582-3589, 2010.

N. L. Grimsey, C. E. Goodfellow, M. Dragunow, and M. Glass, Cannabinoid receptor 2 undergoes Rab5-mediated internalization and recycles via a Rab11-dependent pathway, Biochim. Biophys. Acta, vol.1813, pp.1554-1560, 2011.

A. C. Magalhaes, H. Dunn, and S. S. Ferguson, Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins, Br. J. Pharmacol, vol.165, pp.1717-1736, 2012.

K. L. Mccoy, Interaction between cannabinoid system and toll-like receptors controls inflammation, Mediators Inflamm, p.5831315, 2016.

M. T. Samson, A. Small-howard, L. M. Shimoda, M. Koblan-huberson, A. J. Stokes et al., Differential roles of CB1 and CB2 cannabinoid receptors in mast cells, J. Immunol, vol.170, pp.4953-4962, 2003.

T. Iuvone, D. De-filippis, A. Di-spiezio, A. Sardo, S. D'amico et al., Selective CB2 up-regulation in women affected by endometrial inflammation, J. Cell. Mol. Med, vol.12, pp.661-670, 2008.

G. Cantarella, M. Scollo, L. Lempereur, G. Saccani-jotti, F. Basile et al., Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells, Biochem. Pharmacol, vol.82, pp.380-388, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00718032

D. De-filippis, T. A.-d'amico, and . Iuvone, Cannabinomimetic control of mast cell mediator release: New perspective in chronic inflammation, J. Neuroendocrinol, vol.20, pp.20-25, 2008.

F. Facchinetti, E. Giudice, S. Furegato, M. Passarotto, and A. Leon, Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide, Glia, vol.41, pp.161-168, 2003.

R. Gallily, A. Breuer, and R. Mechoulam, 2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice, Eur. J. Pharmacol, vol.406, pp.5-7, 2000.

G. Krishnan and N. Chatterjee, Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation, Glia, vol.60, pp.1629-1645, 2012.

A. Lourbopoulos, N. Grigoriadis, R. Lagoudaki, O. Touloumi, E. Polyzoidou et al., Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis, Brain Res, vol.1390, pp.126-141, 2011.

Y. Lu, F. Peng, M. Dong, and H. Yang, Endocannabinoid 2-arachidonylglycerol protects primary cultured neurons against LPS-induced impairments in rat caudate nucleus, J. Mol. Neurosci, vol.54, pp.49-58, 2014.

D. Panikashvili, N. A. Shein, R. Mechoulam, V. Trembovler, R. Kohen et al., The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines, Neurobiol. Dis, vol.22, pp.257-264, 2006.

Y. H. Chang, S. T. Lee, and W. Lin, Effects of cannabinoids on LPSstimulated inflammatory mediator release from macrophages: involvement of eicosanoids, J. Cell. Biochem, vol.81, pp.715-723, 2001.

R. G. Pertwee and R. A. Ross, Cannabinoid receptors and their ligands, Prostaglandins Leukot. Essent. Fatty Acids, vol.66, pp.101-121, 2002.

S. Galiègue, S. Mary, J. Marchand, D. Dussossoy, D. Carrière et al., Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations, Eur. J. Biochem, vol.232, pp.54-61, 1995.

T. Sugiura and K. Waku, 2-Arachidonoylglycerol and the cannabinoid receptors, Chem. Phys. Lipids, vol.108, pp.89-106, 2000.

S. Munro, K. L. Thomas, and M. Abu-shaar, Molecular characterization of a peripheral receptor for cannabinoids, Nature, vol.365, pp.61-65, 1993.

P. Carayon, J. Marchand, D. Dussossoy, J. M. Derocq, O. Jbilo et al., Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation, Blood, vol.92, pp.3605-3615, 1998.

W. Gonsiorek, C. Lunn, X. Fan, S. Narula, D. Lundell et al., Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide, Mol. Pharmacol, vol.57, pp.1045-1050, 2000.

N. Germain, E. Boichot, C. Advenier, E. V. Berdyshev, and V. Lagente, Effect of the cannabinoid receptor ligand, WIN 55,212-2, on superoxide anion and TNF-alpha production by human mononuclear cells, Int. Immunopharmacol, vol.2, pp.537-543, 2002.

F. Correa, L. Mestre, F. Docagne, and C. Guaza, Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling, Br. J. Pharmacol, vol.145, pp.441-448, 2005.

S. Merighi, S. Gessi, K. Varani, D. Fazzi, P. Mirandola et al., Cannabinoid CB(2) receptor attenuates morphine-induced inflammatory responses in activated microglial cells, Br. J. Pharmacol, vol.166, pp.2371-2385, 2012.

H. Gui, Y. Sun, Z. M. Luo, D. F. Su, S. M. Dai et al., Cannabinoid receptor 2 protects against acute experimental sepsis in mice, Mediators Inflamm, p.741303, 2013.

Y. Zhao, Y. Liu, W. Zhang, J. Xue, Y. Z. Wu et al., WIN55212-2 ameliorates atherosclerosis associated with suppression of pro-inflammatory responses in ApoE-knockout mice, Eur. J. Pharmacol, vol.649, pp.285-292, 2010.

E. V. Berdyshev, P. C. Schmid, R. J. Krebsbach, and H. H. Schmid, Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells, FASEB J, vol.15, pp.2171-2178, 2001.

K. Varga, J. A. Wagner, D. T. Bridgen, and G. Kunos, Platelet-and macrophage-derived endogenous cannabinoids are involved in endotoxininduced hypotension, FASEB J, vol.12, pp.1035-1044, 1998.

D. Marzo, V. , T. Bisogno, L. De-petrocellis, D. Melck et al., Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages, Eur. J. Biochem, vol.264, pp.258-267, 1999.

O. T. Le, T. T. Nguyen, and S. Y. Lee, Phosphoinositide turnover in Toll-like receptor signaling and trafficking, BMB Rep, vol.47, pp.361-368, 2014.

M. Reisenberg, P. K. Singh, G. Williams, and P. Doherty, The diacylglycerol lipases: structure, regulation and roles in and beyond endocannabinoid signalling, Philos. Trans. R. Soc. Lond. B Biol. Sci, vol.367, pp.3264-3275, 2012.

M. E. Pérez-roque, S. J. Pasquaré, P. I. Castagnet, and N. M. Giusto, Can phosphorylation and dephosphorylation of rod outer segment membranes affect phosphatidate phosphohydrolase and diacylglycerol lipase activities? Comp, Biochem. Physiol. B Biochem. Mol. Biol, vol.119, pp.85-93, 1998.

T. A. Rosenberger, A. A. Farooqui, and L. A. Horrocks, Bovine brain diacylglycerol lipase: substrate specificity and activation by cyclic AMPdependent protein kinase, Lipids, vol.42, pp.187-195, 2007.

J. Song, M. J. Duncan, G. Li, C. Chan, R. Grady et al., A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells, PLoS Pathog, vol.3, p.60, 2007.

A. T. Matthews, J. H. Lee, A. Borazjani, L. C. Mangum, X. Hou et al., Oxyradical stress increases the biosynthesis of 2-arachidonoylglycerol: involvement of NADPH oxidase, Am. J. Physiol. Cell Physiol, vol.311, pp.960-974, 2016.

A. Singh, V. Singh, R. L. Tiwari, T. Chandra, A. Kumar et al., The IRAK-ERK-p67phox-Nox-2 axis mediates TLR4, 2-induced ROS production for IL-1b transcription and processing in monocytes, Cell. Mol. Immunol, vol.13, pp.745-763, 2016.

S. Keck, I. Müller, G. Fejer, I. Savic, S. Tchaptchet et al., Absence of TRIF signaling in lipopolysaccharide-stimulated murine mast cells, J. Immunol, vol.186, pp.5478-5488, 2011.

M. Avila, A. Martinez-juarez, A. Ibarra-sanchez, and C. Gonzalez-espinosa, Lyn kinase controls TLR4-dependent IKK and MAPK activation modulating the activity of TRAF-6/TAK-1 protein complex in mast cells, Innate Immun, vol.18, pp.648-660, 2012.

A. Martín-Á-vila, J. Medina-tamayo, A. Ibarra-sánchez, G. Vázquez-victorio, J. I. Castillo-arellano et al., Protein tyrosine kinase Fyn regulates TLR4-elicited responses on mast cells controlling the function of a PP2a-PKCa/b signaling node leading to TNF secretion, J. Immunol, vol.196, pp.5075-5088, 2016.

J. J. Seeley and S. Ghosh, Molecular mechanisms of innate memory and tolerance to LPS, J. Leukoc. Biol, vol.101, pp.107-119, 2017.

K. Heger, K. Fierens, J. C. Vahl, A. Aszodi, K. Peschke et al., A20-deficient mast cells exacerbate inflammatory responses in vivo, PLoS Biol, vol.12, p.1001762, 2014.

Y. J. Jeon, K. H. Yang, J. T. Pulaski, and N. E. Kaminski, Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor-kappa B/Rel activation, Mol. Pharmacol, vol.50, pp.334-341, 1996.

S. V. More, J. Y. Park, B. W. Kim, H. Kumar, H. W. Lim et al., Anti-neuroinflammatory activity of a novel cannabinoid derivative by inhibiting the NF-kB signaling pathway in lipopolysaccharide-induced BV-2 microglial cells, J. Pharmacol. Sci, vol.121, pp.119-130, 2013.

V. Rubovitch, M. Gafni, and Y. Sarne, The involvement of VEGF receptors and MAPK in the cannabinoid potentiation of Ca2+ flux into N18TG2 neuroblastoma cells, Brain Res. Mol. Brain Res, vol.120, pp.138-144, 2004.

M. Bouaboula, C. Poinot-chazel, B. Bourrié, X. Canat, B. Calandra et al., Activation of mitogenactivated protein kinases by stimulation of the central cannabinoid receptor CB1, Biochem. J, vol.312, pp.637-641, 1995.

E. Rozengurt, Mitogenic signaling pathways induced by G proteincoupled receptors, J. Cell. Physiol, vol.213, pp.589-602, 2007.

M. Guha and N. Mackman, The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells, J. Biol. Chem, vol.277, pp.32124-32132, 2002.

F. Jean-alphonse and A. C. Hanyaloglu, Regulation of GPCR signal networks via membrane trafficking, Mol. Cell. Endocrinol, vol.331, pp.205-214, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00654486

M. Zerial and H. Mcbride, Rab proteins as membrane organizers, Nat. Rev. Mol. Cell Biol, vol.2, pp.107-117, 2001.

J. T. Castaneda, A. Harui, S. M. Kiertscher, J. D. Roth, and M. D. Roth, Differential expression of intracellular and extracellular CB(2) cannabinoid receptor protein by human peripheral blood leukocytes, J. Neuroimmune Pharmacol, vol.8, pp.323-332, 2013.

Y. I. Jong, S. K. Harmon, and K. L. O'malley, GPCR signaling from within the cell, Br. J. Pharmacol, vol.175, pp.4026-4035, 2018.

X. Tian, D. S. Kang, and J. L. Benovic, 2014. b-Arrestins and G proteincoupled receptor trafficking, Handb. Exp. Pharmacol, vol.219, pp.173-186

A. Dhopeshwarkar and K. Mackie, CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?, Mol. Pharmacol, vol.86, pp.430-437, 2014.

J. L. Seachrist and S. S. Ferguson, Regulation of G proteincoupled receptor endocytosis and trafficking by Rab GTPases, Life Sci, vol.74, pp.225-235, 2003.

C. Progida, L. Cogli, F. Piro, A. De-luca, O. Bakke et al., Rab7b controls trafficking from endosomes to the TGN, J. Cell Sci, vol.123, pp.1480-1491, 2010.

A. M. Piliponsky and L. Romani, The contribution of mast cells to bacterial and fungal infection immunity, Immunol. Rev, vol.282, pp.188-197, 2018.

E. A. Deitch, Rodent models of intra-abdominal infection, Shock, vol.24, pp.19-23, 2005.

K. M. Nautiyal, H. Mckellar, A. J. Silverman, and R. Silver, Mast cells are necessary for the hypothermic response to LPS-induced sepsis, Am. J. Physiol. Regul. Integr. Comp. Physiol, vol.296, pp.595-602, 2009.

N. Acharya, S. Penukonda, T. Shcheglova, A. T. Hagymasi, S. Basu et al., Endocannabinoid system acts as a regulator of immune homeostasis in the gut, Proc. Natl. Acad. Sci. USA, vol.114, pp.5005-5010, 2017.